Subscribe Now Subscribe Today
Research Article
 

Biochemical and Ultrastructure Changes in the Kidney of Streptozotocin-Induced Diabetic Rat



Abdullah G. Al-Kushi
 
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail
ABSTRACT

Diabetes mellitus alters the cellular production of eicosanoids in a number of tissues, including the kidney and these agents have in true been implicated in the pathogenesis of diabetic nephropathy. The aim of this work was to study the effect of streptozotocin-induced diabetes on a kidney by light and electron microscopy. Twenty four adult male white albino rats were collected and classified into 2 main groups. The first (treated) group by a single Streptozotocin (STZ) injection (60 mg/kg) intra-peritoneal (i.p). The second group was considered control. The blood samples were collected for Fasting Blood Sugar (FBS), cholesterol, creatinine and triglycerides The survival rate in diabetic rats was 66.6% in contrast to 100% in controls. There was a significant weight loss (p = 0.01) in diabetic rats while a highly significant weight gain (p = 0.002) was recorded in control ones. The kidney weight in diabetic rats showed an extremely significant increase (p = <0.004). The rats injected with STZ have shown severe hyperglycaemia (p<0.0001). Serum cholesterol showed a highly significant rise in both diabetic (p = 0.007) and control rats (p = 0.001). Both creatinine values (p<0.0001) and serum triglycerides (p = 0.0004) were significantly higher in diabetic rats than in control rats. The kidney of induced diabetic rats showed a Histopathological and ultrastructure changes in both kidney. In conclusion, STZ-induced diabetes mellitus had deleterious effects in both structure and function of the rat kidney. Intensive management of diabetes mellitus in human is recommended to delay or prevent such diabetic nephropathy.

Services
Related Articles in ASCI
Similar Articles in this Journal
Search in Google Scholar
View Citation
Report Citation

 
  How to cite this article:

Abdullah G. Al-Kushi , 2013. Biochemical and Ultrastructure Changes in the Kidney of Streptozotocin-Induced Diabetic Rat. Pakistan Journal of Nutrition, 12: 313-321.

DOI: 10.3923/pjn.2013.313.321

URL: https://scialert.net/abstract/?doi=pjn.2013.313.321

REFERENCES
1:  Aguila, M.B. and C.A. Mandarim-de-Lacerda, 2003. Effects of chronic high fat diets on renal function and cortical structure in rats. Exp. Toxicol. Pathol., 55: 187-195.
CrossRef  |  

2:  Besse, S., P. Assayag, C. Delcayre, F. Carre, S.L. Cheav, Y. Lecarpentier and B. Swynghedauw, 1993. Normal and hypertrophied senescent rat heart: Mechanical and molecular characteristics. Am. J. Physiol., 265: H183-H190.
Direct Link  |  

3:  Budneck, L., 1987. Statistics. In: Preventive Medicine and Public Health, Cassem, B.J. (Ed.). John Wiley and Sons, New York, USA., pp: 43-77.

4:  Carlson, L.A., A.M. Gotto and D.R. Illingworth, 2001. Current Hyperlipidaemia. 2nd Edn., Science Press, USA., pp: 3-13.

5:  DeRubertis, F.R. and P.A. Craven, 1993. Eicosanoids in the pathogenesis of the functional and structural alterations of the kidney in diabetes. Am. J. Kidney Dis., 22: 727-735.
PubMed  |  

6:  Dnyanmote, A.V., S.P. Sawant, E.A. Lock, J.R. Latendresse, A.A. Warbritton and H.M. Mehendale, 2006. Calpastatin overexpression prevents progression of S-1,2-dichlorovinyl-l-cysteine (DCVC)-initiated acute renal injury and renal failure (ARF) in diabetes. Toxicol. Applied Pharmacol., 215: 146-157.
CrossRef  |  

7:  Frankel, B.J., A.M. Heldt, G.C. Gerritsen and G.M. Grodsky, 1984. Insulin, glucagons and somato statin release from prediabetic Chinese hamster. Diabetologia, 27: 387-391.
CrossRef  |  

8:  Gross, M.L., K. Amann and E. Ritz, 2005. Nephron number and renal risk in hypertension and diabetes. J. Am. Soc. Nephrol., 16: S27-S29.
PubMed  |  

9:  Ina, K., H. Kitamura, S. Tatsukawa, T. Takayama and Y. Fujikura, 2002. Glomerular podocyte endocytosis of the diabetic rat. J. Electron. Microsc., 51: 275-279.
PubMed  |  

10:  Islas-Andrade, S., M.C.R.R. Monsalve, J.E. de la Pena, A.C. Polanco, M.A. Palomino and A.F. Velasco, 2000. Streptozotocin and alloxan in experimental diabetes: Comparison of the two models in rats. Acta Histochem. Cytochemica, 33: 201-208.
Direct Link  |  

11:  Kannel, W.B., T.R. Dawber, A. Kagan, N. Revotskie and J. Stokes, 1961. Factors of risk in the development of coronary heart disease: Six-year-follow-up experience: The Framingham study. Arch. Internal Med., 55: 33-50.
CrossRef  |  

12:  Lee, S.I., D.W. Lee and K.S. Kim, 2001. Effect of oestrogen on endothelial dysfunction in postmenopausal women with diabetes. Diabetes Res. Clin. Pract., 54: S81-S92.

13:  Murali, B., D.N. Umrani and R.K. Goya, 2003. Effect of chronic treatment with losartan on streptozotocin-induced renal dysfunction. Mol. Cell Biochem., 249: 85-90.
Direct Link  |  

14:  Medeiros, F.J., M.B. Aguila and C.A. Mandarim-de-Lacerdo, 2006. Renal cortex remodeling in streptozotocin-induced diabetic spontaneously hypertensive rats treated with olive oil, palm oil and fish oil from Menhaden. Prostaglandins Leukotrienes Essential Fatty Acids, 75: 357-365.
CrossRef  |  

15:  Obineche, E.N., E. Mensah-Brown, S.I. Chandranath, I. Ahmed, O. Naseer and A. Adem, 2001. Changes of macrovascular endothelial ultrastructure and gene expression of endothelial nitric oxide synthase in diabetic rats. Arch. Physiol. Biochem., 109: 241-245.
PubMed  |  

16:  Oskov, H., T.S. Olsen, K. Nilelsn, O.J. Rafaelsen and K. Lundbek, 1965. Kidney lesions in rats with severe long-term alloxan diabetes. Diabetologia, 1: 172-179.
CrossRef  |  

17:  Osterby, R., I.B. Brekke, H.J. Gundersen, H.E. Jorgensen and H. Lokkegaard et al., 1984. Quantitative studies of glomerular ultrastructure in human and experimental diabetes. Applied Pathol., 2: 205-211.
PubMed  |  

18:  Pesce, C., S. Menini, F. Pricci, A. Favre, G. Leto, U. DiMario and G. Pugliese, 2002. Glomerular cell replication and cell loss through apoptosis in experimental diabetes mellitus. Nephron, 90: 484-488.
Direct Link  |  

19:  Rasch, R., 1979. Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment. Kidney size and glomerular volume. Diabetologia, 16: 125-128.

20:  Saito, M., Y. Kinoshita, I. Satoh, C. Shinbori and T. Kono et al., 2006. N-hexacosanol ameliorates streptozotocin-induced diabetic rat nephropathy. Eur. J. Pharmacol., 544: 132-137.
CrossRef  |  

21:  Seyer-Hansen, K., 1983. Renal hypertrophy in experimental diabetes mellitus. Kidney Int., 23: 643-646.
PubMed  |  

22:  Stearns, S.B., H.M. Tepperman and J. Tepperman, 1979. Studies on the utilization and mobilization of lipid in skeletal muscles from streptozotocin-diabetic and control rats. J. Lipid Res., 20: 654-662.
PubMed  |  

23:  Tanaka, K., T. Moriya, S. Ohno and Y. Yajma, 1996. The three-dimensional ultrastructure of diabetic glomeruli revealed by the quick-freezing and deep-etching method. Med. Electron. Microscopy, 29: 13-32.
CrossRef  |  

24:  Thora, C., R. Rasch, H. Stodkilde-Jorgensen and A. Flyvbjer, 1997. Relationship between MRI and morphometric kidney measurements in diabetic and non-diabetic rats. Kidney Int., 51: 50-56.
CrossRef  |  

25:  White, S.I., A. Cass, R.C. Atkins and S.J. Chadban, 2005. Chronic kidney disease in the general population. Adv. Chronic Kidney Dis., 12: 5-13.
CrossRef  |  

©  2020 Science Alert. All Rights Reserved